Skip to main content
. 2020 Jul 4;13:100293. doi: 10.1016/j.bonr.2020.100293

Fig. 2.

Fig. 2

Percent changes in serum TRACP-5b (A) and P1NP (B) from baseline to 24 months. Error bars: SEM. *P < 0.05, **P < 0.01, ***P < 0.001 vs. baseline. †P < 0.001, Denosumab group vs. Teriparatide group. TRACP-5b, tartrate-resistant acid phosphatase 5b; P1NP, procollagen type 1 N-terminal propeptide.